Life Science News

RSS

View News A-Z »

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech S.A., a leading international technology partner of the biopharmaceutical industry, has been selected by ABL Europe as its primary supplier of single-use systems.

From Sartorius 21 Mar 2018

Research provides better understanding of how cancerous cells behave in low oxygen

Research provides better understanding of how cancerous cells behave in low oxygen

An international team of researchers found how cancer cells respond to DNA damage signaling when in low oxygen, or hypoxia.

21 Mar 2018

Researchers succeed in integrating artificial organelles into cells of living organism

Researchers succeed in integrating artificial organelles into cells of living organism

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.

20 Mar 2018

Columbia researchers identify nerve cells that drive fruit fly's escape behavior

Columbia researchers identify nerve cells that drive fruit fly's escape behavior

Columbia University researchers have identified the nerve cells that initiate a fly's escape response: that complex series of movements in which an animal senses, and quickly maneuvers away from, something harmful such as high heat.

20 Mar 2018

Researchers discover 'missing mutation' in severe infant epilepsy

Researchers discover 'missing mutation' in severe infant epilepsy

Researchers have discovered a "missing mutation" in severe infant epilepsy--long-suspected genetic changes that might trigger overactive, brain-damaging electrical signaling leading to seizures.

20 Mar 2018

Researchers uncover specific gene region in hypertension

Researchers uncover specific gene region in hypertension

Genes encode proteins and proteins dictate cell function. Therefore, the thousands of genes expressed in a cell determine what that cell can do.

20 Mar 2018

Scientists uncover new answers to cell aging in children with rare, fatal disease

Scientists uncover new answers to cell aging in children with rare, fatal disease

In a recent paper published in Cell Reports, Saint Louis University researchers have uncovered new answers about why cells rapidly age in children with a rare and fatal disease.

20 Mar 2018

New guide for selecting optimum microplate closure and sealing devices

New guide for selecting optimum microplate closure and sealing devices

Porvair Sciences, in conjunction with sister company – JG Finneran Associates Inc., has produced a new informative guide to assist lab scientists select the optimum seal and closure device for different types of microplate.

From Porvair Sciences Limited 20 Mar 2018

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organization as work done in the 100,000 Genomes Project provides the foundation for the systems NHS England is mobilizing in its ground breaking Genomic Medicine Service.

From Genomics England 20 Mar 2018

Groundbreaking 100,000 Genomes Project achieves important milestone to transform NHS care

Groundbreaking 100,000 Genomes Project achieves important milestone to transform NHS care

The Department of Health and Social Care, NHS England and Genomics England today announced reaching the 50,000 whole human genome sequences landmark within the 100,000 Genomes Project.

From Genomics England 20 Mar 2018

Wales participates in the 100,000 Genomes Project

Wales participates in the 100,000 Genomes Project

Wales has joined the 100,000 Genomes Project, the Welsh Government announced today. The project, now a UK-wide initiative, seeks to transform patient care, encourage genomic discovery and drive a thriving genomics sector.

From Genomics England 20 Mar 2018

Verge joins Genomics England’s Discovery Forum industry partnership

Verge joins Genomics England’s Discovery Forum industry partnership

Genomics England and Verge Genomics, a leading artificial intelligence therapeutics company, announced today that Verge will join Genomics England’s Discovery Forum industry partnership. The partnership aims to translate groundbreaking research into innovative treatments, and ultimately patient benefit, as rapidly as possible.

From Genomics England 20 Mar 2018

Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis

Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis

Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England’s Rare Disease Pilot.

From Genomics England 20 Mar 2018

Alex’s experiences of living with rare genetic disease

Alex’s experiences of living with rare genetic disease

In this video, meet participant Alexander Masterson and his mum, Kirsty, who speak about what getting a diagnosis from the 100,000 Genomes Project means to them.

From Genomics England 20 Mar 2018

Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop

Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop

A recent article in the Royal College of Pathologists‘ bulletin provides a summary of our recent Tissue Handling Workshop.

From Genomics England 20 Mar 2018

‘Fast track’ project shows promising results in cancer whole genome analyses

‘Fast track’ project shows promising results in cancer whole genome analyses

One key aim of the 100,000 Genomes Project is to improve cancer care for NHS patients. Whole genome sequencing in cancer can enable clinicians to choose better treatments and improve outcomes for patients through personalized medicine.

From Genomics England 20 Mar 2018

Scotland study aims to offer precise diagnoses for people with rare genetic diseases

Scotland study aims to offer precise diagnoses for people with rare genetic diseases

People in Scotland with rare genetic diseases are set to benefit from a DNA study that seeks to improve their diagnoses and treatments.

From Genomics England 20 Mar 2018

Whole Genome Sequencing used as diagnostic solution for TB

Whole Genome Sequencing used as diagnostic solution for TB

Public Health England has announced that Whole Genome Sequencing (WGS) is now being used to identify different strains of tuberculosis (TB).

From Genomics England 20 Mar 2018

Researchers develop technology to program DNA for delivering cancer drugs

Researchers develop technology to program DNA for delivering cancer drugs

DNA has an important job – it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off.

19 Mar 2018

New optical point-of-care device could enhance screening for thyroid nodules

New optical point-of-care device could enhance screening for thyroid nodules

Early diagnosis in thyroid cancer can improve a patient's likelihood of recovery, but current screening methods use instruments with poor sensitivity and can yield inaccurate results.

19 Mar 2018

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.